TekniPlex Healthcare, an advanced materials science company, will showcase its expertise and intellectual property related to the single-use bioprocessing and the cell and gene therapy markets at INTERPHEX Booth 3837. The company will highlight its biologics portfolio of complementary solutions across the upstream, downstream processing and final fill operations. Solutions include customizable barrier cleanroom films, tubing such as weldable TPE and TPV, silicone and PVC, as well as various compounds for associated molded components.

For cell and gene therapy applications, TekniPlex Healthcare produces and supplies tubing in a variety of configurations, grades and durometers. Both single- and multi-lumen constructions are available, as well as multi-layer versions incorporating complementary materials for performance optimization.

For traditional bioprocess applications, the company produces tight-tolerance biopharm-grade constructions comprised of TPE, TPV and silicones. Each of its offerings covers all stages of the drug development process, from small batch production through scale-up and commercial quantities.

The company will also highlight its coextrusion film capabilities, including newly expanded cleanroom manufacturing capacity for multilayer films suitable for single-use bioprocessing applications. The new ISO 7 cleanroom multilayer blown film line at the company’s Puurs, Belgium facility, joins existing cast coextrusion ISO 7 cleanroom manufacturing capacity suitable for bioprocessing bag film production. The additional film production expands capabilities to provide customizable film solutions to bioprocessing bag manufacturers, with a range of potential resin combinations helping meet durability needs, as well as extractables and leachables profile requirements.

“As the biologics sector continues its steady growth, so does the need for high-quality materials and components suppliers who can also be innovative solutions partners,’ said Chris Qualters, CEO of TekniPlex Healthcare. “With our expanding capacities and innovative mindset, TekniPlex Healthcare is poised and ready to respond to the evolving needs of the sector, providing value-added solutions that help bring life-changing therapies to market.”

About PackGene

PackGene Biotech is a world-leading CRO and CDMO, excelling in AAV vectors, mRNA, plasmid DNA, and lentiviral vector solutions. Our comprehensive offerings span from vector design and construction to AAV, lentivirus, and mRNA services. With a sharp focus on early-stage drug discovery, preclinical development, and cell and gene therapy trials, we deliver cost-effective, dependable, and scalable production solutions. Leveraging our groundbreaking π-alpha 293 AAV high-yield platform, we amplify AAV production by up to 10-fold, yielding up to 1e+17vg per batch to meet diverse commercial and clinical project needs. Moreover, our tailored mRNA and LNP products and services cater to every stage of drug and vaccine development, from research to GMP production, providing a seamless, end-to-end solution.

Related News

Related Services

Plasmids GMP Services

Multiple scales & grade of solutions of various kind of plasmids suitable for multiple treatments in a fast and cost effective way.

AAV GMP Services

Ranging from small-scale AAV production, to large-scale AAV cGMP manufacturing for animal studies.
aav icon

Technology Platforms

PackGene’s proprietary π-Alpha™ 293 AAV High-yield Platform increases AAV production by 3 to 8 times that of traditional platforms.